HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effect of eviprostat on bladder overactivity in an experimental cystitis rat model.

AbstractOBJECTIVE:
The purpose of this study was to investigate the effects of eviprostat, a phytotherapeutic drug, on bladder overactivity and inflammation in a cyclophosphamide (CYP)-induced cystitis rat model.
METHODS:
Female Sprague-Dawley rats received a single intraperitoneal injection of CYP (200 mg/kg) or saline. After the CYP injection, eviprostat (9, 18 or 54 mg/kg per day) or a vehicle was orally given twice each day. Four days after the CYP injection, bladder function was evaluated by cystometrograms under urethane anesthesia. In a separate group, bladder inflammation was compared between the eviprostat- or vehicle-treated animals. Furthermore, the effects of eviprostat on carbachol-induced muscle contraction were evaluated by an in vitro experiment.
RESULTS:
The intercontraction interval (ICI) significantly decreased in the CYP-injected rats in comparison to the saline-injected rats. In the CYP-injected group, 18 and 54 mg/kg per day of eviprostat treatment significantly increased the ICI, but did not change the maximum voiding pressure in comparison to the vehicle treatment. In the saline-injected group, no significant changes of any parameters in the cystometrograms were observed between the eviprostat- and vehicle-treated groups. CYP-induced bladder inflammation tended to be lower in the eviprostat-treated group in comparison to the vehicle-treated group. An in vitro experiment revealed that eviprostat failed to inhibit carbachol-induced muscle contraction.
CONCLUSION:
The oral administration of eviprostat suppressed CYP-induced bladder overactivity. The effects of eviprostat on the micturition reflex may be irrespective of antimuscarinic action. The present findings raise the possibility that eviprostat could be an effective treatment for bladder overactivity associated with inflammation.
AuthorsMizuki Kobayashi, Masayoshi Nomura, Hisae Nishii, Seiji Matsumoto, Naohiro Fujimoto, Tetsuro Matsumoto
JournalInternational journal of urology : official journal of the Japanese Urological Association (Int J Urol) Vol. 15 Issue 4 Pg. 356-60 (Apr 2008) ISSN: 1442-2042 [Electronic] Australia
PMID18380828 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antineoplastic Agents, Alkylating
  • Cholinergic Agonists
  • Drug Combinations
  • Plant Extracts
  • Ethamsylate
  • eviprostat
  • Cyclophosphamide
  • Carbachol
Topics
  • Animals
  • Antineoplastic Agents, Alkylating
  • Carbachol
  • Cholinergic Agonists
  • Cyclophosphamide
  • Cystitis (chemically induced, drug therapy, pathology)
  • Drug Combinations
  • Ethamsylate (pharmacology, therapeutic use)
  • Female
  • Muscle Contraction (drug effects)
  • Organ Size (drug effects)
  • Phytotherapy
  • Plant Extracts (pharmacology, therapeutic use)
  • Rats
  • Rats, Sprague-Dawley
  • Urinary Bladder (drug effects, pathology)
  • Urinary Bladder, Overactive (chemically induced, drug therapy, pathology)
  • Urination (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: